Beckwith-Wiedemann Syndrome (BWS)
par Alisha Preti

1. Diagnostic Tests
1.1. Based on clinical assessment, a baby can be diagnosed if expressing one or more clinical manifestations.
1.2. Diagnosis is confirmed by genetic testing.
1.3. In extreme cases diagnosis can be determined by ultrasound.
2. Chromosome Involved
2.1. Genetic testing can determine if the cause is epigenetic or genomic alterations of the chromosome 11p15.5
2.2. The gene is found on two separate differentially methylated regions (DMR), a normal person only has one active gene that encodes insulin-like growth factor (IGF). With BWS the person has 2 on the paternal side or a loss of imprinting on the maternal side causing the gene to be double,
3. Causative Factors
3.1. Loss of methylation on the maternal chromosome at the imprinting center 2 (IC2)
3.2. Paternal uniparental disomy for chromosome 11p15
3.3. Gain of methylation during maternal chromosome during imprinting at center 1
4. Pathophysiology
4.1. During fetal development this gene alteration causes increased production of insulin-like growth factor 2.
4.1.1. This over production contributes to the overgrowth features.
4.1.2. Because this disease can happen during DNA imprinting there is not an exact set of symptoms, growth is inappropriately inhibited in different regions of the body.